HOW WAS IT TRIALLED?
The Phase 1 trial involved 1,077 healthy adults aged 18-55 with no history of Covid-19.
Among these, 543 received the vaccine while 534 people were given a non-covid vaccine to serve as a control group
The Phase 1 trial involved 1,077 healthy adults aged 18-55 with no history of Covid-19.
Among these, 543 received the vaccine while 534 people were given a non-covid vaccine to serve as a control group